发明名称 DIARYLALKANES AS POTENT INHIBITORS OF BINUCLEAR ENZYMES.
摘要 The present invention implements a strategy that combines an enzyme inhibition assay with a chemical dereplication process to identify active plant extracts and the particular compounds - diarylalkanes and/or diarylalkanols within those extracts that specifically inhibit binuclear enzyme function. Included in the present invention are compositions of matter comprised of one or more of diarylalkanes and/or diarylalkanols, which inhibit the activity of binuclear enzymes, particularly tyrosinase and which prevent melanin overproduction. The present invention also provides a method for inhibiting the activity of a binuclear enzyme, particularly tyrosinase and a method for preventing and treating diseases and conditions related to binuclear enzyme function. The present invention further includes a method for preventing and treating melanin overproduction and diseases and conditions of the skin related thereto. The method for preventing and treating diseases and conditions related to binuclear enzyme function and melanin overproduction is comprised of administering to a host in need thereof an effective amount of a composition comprising one or more diarylalkanes and/or diarylalkanols synthesized and/or isolated from one or more plants together with a pharmaceutically acceptable carrier.
申请公布号 MXPA06013705(A) 申请公布日期 2007.02.13
申请号 MX2006PA13705 申请日期 2005.05.27
申请人 UNIGEN PHARMACEUTICALS, INC. 发明人 QI JIA;JI-FU ZHAO
分类号 A61K31/015;A61K31/05;A61K31/704;C07C39/15;C07C39/367;C07C43/23;C07C45/67;C07C49/835;C07C215/74;C07D321/12 主分类号 A61K31/015
代理机构 代理人
主权项
地址